ADAI News & Events
November 20, 2025
Northwest ATTC & FADU Webinar: Meeting Clients Where They Are: Using a Neuro-Informed Lens (Dec. 3, 2025, 12pm PT)
Join the Northwest ATTC on December 3, 2025 (12-1pm PT) for their next webinar, featuring Linda Segur, a professional with over 35 years of experience in human services, specializing in families impacted by substance use, poverty, and mental health issues. This session is co-sponsored by ADAI’s Fetal Alcohol & Drug Unit (FADU). Meeting Clients Where They Are:…
November 6, 2025
ADAI Virtual Lunch & Learn: Quantifying Cannabis/THC Exposure During Pregnancy (Nov. 20, 2025, 12pm PT)
Join us on Zoom for our next ADAI Lunch & Learn session, November 20, 2025 from 12-1pm PT! Quantification and prediction of human fetal THC exposure during pregnancy to inform fetal cannabis toxicity Jashvant (Jash) D. Unadkat, Ph.D.Professor, Dept. of PharmaceuticalsUniversity of Washington Prenatal cannabis use is associated with neurodevelopmental deficits, likely due to exposure…
November 4, 2025
ADAI Virtual Research Open House: Nov. 12 (5:30-7pm PT)
Are you interested in working in substance use / addiction research? Join us on November 12, 2025 (5:30-7pm PT) for our next ADAI Virtual Research Open House! Come hear from ADAI faculty and staff about the wide variety of work we do, including research, implementation, training/education, data science, information services, and more! This event is…
October 17, 2025
New ICD-10-CM Code for Cannabinoid Hyperemesis Syndrome: R11.16
A new ICD-10-CM diagnosis code for Cannabinoid Hyperemesis Syndrome (CHS) went into effect on October 1, 2025. ICD-10-CM codes are used to classify different medical diagnoses, symptoms, and procedures in health records and for billing and claims processing. To date, most health systems have documented CHS using a combination of codes for nausea and vomiting, such…
October 16, 2025
New Videos in the Mental Health Topics for Non-Therapist Professionals Series
The Mental Health Topics for Non-Therapist Professionals series on the LearnAboutTreatment.org website, produced by the ADAI State Opioid Response Training Team, is for providers who work with people with a substance use disorder (SUD) but are not trained as mental health therapists. The goal is to boost knowledge of mental health issues, especially those common…
New Naloxone and Overdose Resources from the WA Department of Health
The WA State Department of Health (DOH) has some new resources out about naloxone and overdose. Issue Brief: The Risks of High-Dose Naloxone Products and Nalmefene for Community Opioid Overdose Response In this issue brief, DOH provides a summary of the current data and their recommendations on opioid overdose reversal medication types and dosages. Key…
October 15, 2025
Upcoming Northwest ATTC Webinars: The Power of Affirming Care (Oct 29) and Gaming Disordered Clients (Nov 5)
Join the Northwest ATTC this fall for two back-to-back webinar sessions! Certificate of Attendance available to all attendees of the live sessions. The Power of Affirming Care in SUD Recovery October 29, 2025 | 12pm-1:pm PTRegister here!Sponsored by the Northwest ATTC and the Washington Recovery Alliance. Affirming care is more than a value—it is a vital…
October 14, 2025
RECORDING AVAILABLE: Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State (Oct. 14, 2025)
The Bree Collaborative and UW Addictions, Drug & Alcohol Institute hosted a webinar, Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State, on October 14, 2025. This webinar explored how individuals across Washington State access treatment for opioid use disorder (OUD), with a focus on the implementation of medications for opioid use disorder (MOUD) in a…
September 26, 2025
Carfentanil: What Are We Seeing in Washington State?
From the UW Center for Community-Engaged Drug Education, Epidemiology & Research at the Addictions, Drug & Alcohol Institute The DEA recently reported that more than 50,000 fake pharmaceutical pills were seized by law enforcement in Western Washington. The pills were labeled with “M30” and designed to look like oxycodone. In recent years such pills typically…
September 16, 2025
New ADAI Publication: Expanding the Contingency Management Workforce to Include Peer Specialists
Citation: Hartzler B, et al. Reason to expand the contingency management workforce: Coaching-to-criterion results for addiction professionals and peer specialists. Subst Use Addict 2025 (in press). [doi: 10.1177/29767342251363007] Contingency management (CM) is a type of behavior therapy that uses rewards to motivate people in treatment for substance use disorder. These rewards encourage positive treatment behaviors,…
Next page
